NewsBenzingaSenti Biosciences dépose un prospectus couvrant la revente de jusqu'à 25 555 024 actions ordinaires offertes par les détenteurs de titres vendus. Senti Biosciences dépose un prospectus couvrant la revente de jusqu'à 25 555 024 actions ordinaires offertes par les détenteurs de titres vendus. Benzinga 2026.09.24 21:01 (GMT+0) Open on Benzinga Other news Motorola Solutions Hikes Quarterly Dividend From $1.21 To $1.34 Per Share These 9 Congress Members Could Have Increased Interest in Nvidia’s Q3 Earnings as 2026 Shareholders $100 Invested In Cigna Group 20 Years Ago Would Be Worth This Much Today Needham Maintains Buy on FuboTV, Lowers Price Target to $10 BTIG Reiterates Buy on Amer Sports, Maintains $42 Price Target Ahead of Palo Alto Networks Earnings, Here's What Barchart Data Says Comes Next for PANW Stock